Colfax CORP CFX Cash Flow

Colfax corp (CFX)

CashFlow / Yearly

Dec'19	Dec'18	Dec'17	Dec'16	Dec'15	Dec'14	Dec'13	Dec'12	Dec'11	Dec'10	Dec'09
Net income
-517,146	154,473	169,507	145,191	187,178	420,273	209,143	-42,264	4,555	16,215	23,797
Adjustments to reconcile net income to net cash provided by operating activities:
Divestiture impairment loss
449,000	0	0	-	-	-	-	-	-	-	-
Impairment of goodwill, intangibles and property, plant and equipment
0	7,086	183,751	6,082	12,505	-	-	-	-	-	-
Depreciation and amortization
236,026	141,877	132,203	137,176	142,037	174,724	119,258	183,403	22,598	16,807	15,074
Stock-based compensation expense
21,960	25,103	21,548	19,020	16,321	17,580	13,334	9,373	4,908	3,137	2,593
Non-cash interest expense
9,937	4,415	4,519	4,176	10,101	9,094	44,377	16,997	735	-	-
Loss on Investments
0	-10,128	0	0	-	-	-	-	-	-	-
Deferred income tax expense (benefit)
-590	-66,573	12,066	-1,682	-22,717	-139,488	9,946	7,222	-1,722	-296	2,689
Gain on revaluation of Sicelub investment
-	-	-	-	-	-	13,784	0	0	-	-
Unrealized loss on acquisition-related foreign currency derivative
-	-	-	-	-	-	-	-	-21,146	0	-
Amortization of deferred loan costs
-	-	-	-	-	-	-	-	-	-	677
Loss (gain) on sale of property, plant and equipment
-61	21,108	11,243	-531	0	-	-	-	-	-	64
(Gain) loss on sale of business
14,233	-4,337	308,388	0	0	-	-	-	-	-	-
Pension settlement (gain) loss
77,390	-39	46,933	48	0	-	-	-	-	-	-
Changes in operating assets and liabilities:
Trade receivables, net
-49,924	72,405	44,345	50,958	-64,048	19,916	98,912	37,338	5,972	6,060	-16,280
Inventories, net
44,887	47,156	34,023	-19,665	390	-57,847	-79,987	-26,694	-10,844	-11,598	-10,763
Accounts payable
-119,325	70,085	10,266	37,083	965	-26,038	128,889	88,927	-7,298	12,615	-
Customer advances and billing in excess of costs incurred
-	-	-	37,210	21,094	9,754	-	-	-	-	-
Accounts payable and accrued expenses, excluding asbestos-related accrued expenses
-	-	-	-	-	-	-	-	-	-	-20,899
Other current assets
-	-	-	-	-	-	-	-	-	-	-2,605
Asbestos liability and asbestos-related accrued expense, net of asbestos insurance asset and receivable
-	-	-	-	-	-	-	-	-	-	10,166
Changes in other operating assets and liabilities
17,169	-16,144	-35,976	32,148	85,141	98,564	130,069	78,994	-7,359	-7,949	4,645
Net cash provided by (used in) operating activities
130,948	226,367	218,770	246,974	303,813	385,758	362,169	174,020	57,153	61,965	38,704
Cash flows from investing activities:
Purchases of property, plant and equipment
125,402	69,646	68,765	63,251	69,877	84,458	71,482	83,187	13,624	12,527	11,006
Proceeds from sale of property, plant and equipment
7,781	34,829	21,224	7,249	-	-	-	-	-	-	-
Acquisitions, net of cash received
3,151,056	290,918	346,764	25,992	196,007	948,800	372,476	1,859,645	56,346	27,960	1,678
Proceeds from sale of business, net
1,635,920	18,404	490,308	0	0	-	-	-	-	-	-
Proceeds from Sale of Short-term Investments
0	139,480	0	0	-	-	-	-	-	-	-
Loans to non-trade creditors
-	-	-	-	-	-	31,012	0	0	-	-
Other, net
0	0	6,127	0	-18,927	-3,115	0	-1,857	0	-	-
Proceeds from sale of stock of entity previously controlled
-	-	-	-	-	-	-	-	-	0	-
Cash contribution to unconsolidated entity
-	-	-	-	-	-	-	-	-	0	-
Proceeds from sale of fixed assets
-	-	-	-	-	-	-	-	-	74	219
Net cash used in investing activities
-1,632,757	-167,851	89,876	-81,994	-246,957	-1,030,143	-474,970	-1,940,975	-69,970	-40,413	-12,465
Cash flows from financing activities:
Payments under term credit facility
1,387,500	131,250	65,628	37,500	1,232,872	15,542	679,755	531,415	10,000	8,750	5,000
Proceeds from borrowings under notes and term credit facility
1,725,000	0	0	-	750,000	150,000	50,861	1,731,523	0	0	-
Proceeds from borrowings on revolving credit facilities and other
2,045,083	1,271,051	1,046,457	896,742	1,498,039	1,370,626	648,000	13,149	141,203	5,500	-
Repayments of borrowings on revolving credit facilities and other
2,273,802	981,563	1,632,658	978,024	1,104,055	1,414,146	328,133	53,414	102,180	5,500	-
Proceeds from borrowings on senior unsecured notes
1,000,000	0	374,450	-	-	-	-	-	-	-	-
Proceeds from Notes Payable
-	-	-	0	0	-	-	-	-	-	-
Payment of debt issuance costs
23,380	0	0	-	-	-	-	-	-	-	-
Proceeds from prepaid stock purchase contracts
377,814	0	0	-	-	-	-	-	-	-	-
Proceeds from issuance of common stock, net
11,879	4,699	6,944	2,206	6,052	613,927	324,153	756,762	3,719	912	-
Proceeds from issuance of preferred stock, net
-	-	-	-	-	-	-	332,969	0	0	-
Payment for noncontrolling interest share repurchase
93,505	0	0	-	-	10,338	14,913	29,292	0	-	-
Payments for common stock repurchases
0	200,000	0	20,812	27,367	0	0	-	-	-	-
Preferred stock conversion inducement payment
-	-	-	-	-	19,565	0	-	-	-	-
ESAB India repurchase of additional noncontrolling interest
-	-	-	-	-	-	-	-	-	0	-
Payments of dividend on preferred stock
-	-	-	-	-	3,853	20,396	17,446	0	0	-
Other
-12,095	-10,090	-10,012	-7,830	-21,066	-21,060	-24,870	-19,608	0	0	-
Payments on capital leases
-	-	-	-	-	-	-	-	-	205	417
Net cash provided by financing activities
1,369,494	-47,153	-280,447	-145,218	-131,269	650,049	-45,053	2,183,228	32,742	-8,043	-5,417
Effect of foreign exchange rates on Cash and cash equivalents
-3,072	-28,363	12,090	4,499	-33,566	-11,517	-13,294	-8,932	-5,359	-2,930	379
Supplemental Cash Flow Information [Abstract]
Non-cash consideration received from sale of business
0	0	206,415	0	0	-	-	-	-	-	-
Interest Paid, Excluding Capitalized Interest, Operating Activities
139,268	50,389	43,496	-	-	-	-	-	-	-	-
Interest Paid, Including Capitalized Interest, Operating and Investing Activities
-	-	-	35,838	-	42,041	58,970	79,857	5,209	6,105	6,615
Income Taxes Paid, Net
134,915	97,452	70,668	77,104	-	82,694	93,856	70,677	16,731	5,819	16,596
Increase (decrease) in Cash and cash equivalents
-135,387	-17,000	40,289	-	-	-	-	-	-	-	-
(Decrease) increase in Cash and cash equivalents
-	-	-	24,261	-107,979	-5,853	-171,148	407,341	14,566	10,579	21,201